Will My Cancer Return?

Many colorectal cancer patients worry about this after having a tumor removed and wonder if further treatment is needed. Doctors formulate their recommendations primarily based on the cancer’s severity, or stage. Staging reflects several factors, including whether cancer cells have spread to lymph nodes surrounding the tumor.

Unfortunately, up to 30% of patients who are thought to be cancer-free after surgery experience a recurrence of their cancer, presumably through cancer metastases missed during microscopic examination of the lymph nodes. With recent advances in genomic research, however, more sensitive tests are becoming available.

For example, the technology used in the Previstage™ GCC Colorectal Cancer Staging Test provides 100,000 times more sensitivity than microscopic examination, significantly improving the information available for making critical treatment decisions. This website helps you understand these new advances while sharing information to help you through what can be a very stressful time.

This website, mypersonalcancerdiagnosis.com, was developed by DiagnoCure Oncology Laboratories (DOL), a CLIA-certified laboratory located in West Chester, Pennsylvania. DOL is the developer and provider of the Previstage™ GCC Colorectal Cancer Staging Test. For more information about DiagnoCure Oncology Laboratories, or technical information about Previstage™ GCC, go to www.diagnocurelabs.com